Lisa Fucito, PhD

Associate Professor Term; Director, Tobacco Treatment Service Smilow Cancer Hospital at Yale-New Haven

Research Departments & Organizations

Psychiatry: Center for Nicotine and Tobacco Use Research at Yale (CENTURY) | Division of Addictions | Psychological Medicine Service | Psychology Section | Psychotherapy Development Center | Smoking Cessation and Alcohol Treatment Research Clinic | Substance Abuse Research | Substance Abuse Treatment Center | Yale Tobacco Center of Regulatory Science

Yale Cancer Center: Cancer Prevention and Control

Office of Cooperative Research

Research Interests

Alcoholism; Behavior and Behavior Mechanisms; Psychotherapy; Risk Reduction Behavior; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Smoking Cessation; Tobacco

Research Summary

Cigarette smoking and heavy alcohol consumption are the first and third preventable causes of death and disease in the U.S., respectively. Both also frequently co-occur with other negative health behavior risks such as sleep disturbance and obesity. Despite these health risks, a substantial number of individuals are unable to successfully quit smoking or reduce their drinking. Current efficacious treatments have limitations: (1) not integrated with primary and/or specialty healthcare where most individuals who smoke and/or drink are treated; (2) do not address the multimorbidities that frequently accompany these behaviors; and (3) pose accessibility barriers. There is a need to identify effective integrated models that attenuate healthcare barriers as well as interventions that generalize across multiple negative health behaviors. Multiple health behavior change interventions have the potential to maximize health benefits and reduce health costs.

My research focuses on:

  1. Developing novel, integrated tobacco and alcohol interventions;
  2. Using health feedback (e.g., biosensor data, biomarkers) to motivate health behavior change;
  3. Testing primary healthcare topics (e.g., sleep) as a "gateway" to addressing heavy alcohol consumption and smoking;
  4. Utilizing technology to assess tobacco/alcohol use and deliver interventions to reduce treatment access barriers;
  5. Identifying factors that optimize the efficacy of existing smoking and alcohol interventions;
  6. Examining the mechanisms through which these treatments bring about clinical change.

Specialized Terms: Treatments for tobacco and alcohol use; Moderators of treatment response; Risk behavior mechanisms; Sleep disturbance and substance use; Multiple health behavior change; M-health; Health feedback

Extensive Research Description

Current Research Projects:

Development of a Multimodal Mobile Sleep Intervention Using Wearable Technology to Reduce Heavy Drinking in Young Adults PI: Fucito. Funding: NIAAA R34AA026021. The current proposal will develop and test a mobile sleep/alcohol self-monitoring + sleep/alcohol data feedback intervention in 120 heavy-drinking young adults. The primary objective is to evaluate sleep intervention component feasibility, acceptability, and preliminary efficacy on alcohol outcomes to inform a Stage II randomized trial comparing the final sleep intervention with a standard alcohol intervention. Ultimately, this research could result in an efficacious, low-cost intervention that has broad population reach through the use of technology and a substantial public health impact by reducing alcohol use disorder risk at a crucial developmental stage.

Expanding Cessation Services to all Tobacco-Using Patients within the Yale Cancer Center Network PI: Fuchs, Fucito. Funding: NCI – C3i Initiative, P30CA016359-S. This service implementation project will target tobacco-related risks in cancer patients at Yale Cancer Center. The goal is to increase the number who are screened and treated for tobacco use across the Yale Cancer Center Network statewide.

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs PI: Toll; Yale Site PI: Fucito. Funding: NCI R01CA207229. The purpose of this study is to test a combined behavioral and pharmacological tobacco intervention for promoting smoking cessation among smokers receiving lung cancer screening.





Clinical Trials

Conditions Study Title
Alcohol Addiction Sleep Intervention for Heavy Drinking Young Adults
Lung Personalized Prevention: Smoking Cessation in Patients With a Lung Nodule

Selected Publications

Edit this profile